Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)

CDC: 14 Million Americans Will Have Alzheimer’s by 2060

Biospace, 21 Sep 2018

Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found.